RussianPatents.com

Method of treating apical periodontitis

IPC classes for russian patent Method of treating apical periodontitis (RU 2521204):

A61P1/02 - Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
A61K6/00 - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J0003000000; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L)
A61K31/7036 -
A61K31/47 - Quinolines; Isoquinolines
Another patents in same IPC classes:
Compositions and devices / 2519329
Group of inventions relates to compositions of materials, containing basic aminoacid arginine, and their application for coating devices intended for application in the oral cavity, or for manufacturing such devices. One of composition versions contains basic amino acid arginine, in free form or in form of salt, placed in biodegradable polymer, selected from polyacrylates, polymethacrylates or their copolymers. The other composition version contains matrix with pores from 10 to 70 mcm and basic amino acid arginine, located inside said pores, with matrix representing plastic, selected from polyethylene, polymethylmethacrylate, polyurethane, polyethylene terephthalate, polypropylene, polystyrene, polyamides, bioplastic. Also claimed is application of said compositions of material in production of device for application in the oral cavity, as well as device for application in the oral cavity (for instance, toothbrush, tongue scraper, mouthguard, orthodontic correcting device), which has a surface coated with any of said compositions, and methods of delivery of basic amino acid arginine by means of such device into the oral cavity of a subject, requiring it.
Method of treating periodontitis / 2519121
Method of treating periodontitis provides professional hygienic oral cleansing, antiseptic therapy, local drug-induced therapy. The local drug-induced therapy is two-staged with the use of zeolite-containing fossil flour with particle size of 0.3-0.4 mm. The first stage involves gingival infriction of a mixture consisting of zeolite-containing fossil flour and distilled water taken in equal weight parts for 10-15 min; the second stage includes applications of tampons impregnated with a mixture containing 2.5-3 weight parts of fossil flour and 1-1.5 weight parts of distilled water on the affected gingiva; the length of the local drug-induced therapy is 12-14 days.
Method of treating hypertrophic gingivitis / 2519100
What is used is a preparation in the form of an ointment of the following composition: 70% infusion of Rhaponticum carthamoides rhizomes and roots or Silene tatarica herb - 10.0 ml, 70% infusion of St. John's wort herb - 5.0 ml, 70% infusion of calendula - 5.0 ml, 70% infusion of spiraea - 5.0 ml, clove essence - 1.0 g, Vaseline - 35.0 g, lanolin - 39.0 g used to coat a mucous membrane of the hypertrophied gingiva as an applicate for 15-20 minutes once a day for 14 days; abstaining from food for 2 hours is recommended.
Method for prevention of dental caries / 2518715
Method for prevention of dental caries with using a suspension of the biologically active additive 'Epsorine' involves applications of the suspension either daily, or every second day; the daily procedures contain min 4 applications of the total treatment time up to 20 minutes; the prevention course makes 10 procedures. Besides, the prevention course is repeated 2-3 times a year every 3-4 months for the main indication.
Kit containing photosensitising dyes / 2518473
Invention refers to medicine, particularly to dentistry and concerns preparing an oral care agent. For this purpose, a kit comprising an optically transparent composition containing a photosensitising dye, and a light-emitting device emitting light at a wave length and over a period of time sufficient to activate the photosensitising dye is presented. The above dye is specified in a group consisting of chlorophyllin sodium copper salt, tartrazin (FD&C yellow No.5), riboflavin-5'-monophosphate sodium salt, Allura Red AC (FD&C red No.40), new coccine (CI 16255, edible red 7), chromotrope FB (CI 14720, edible red 3), indigo carmine, erioglaucine disodium salt (FD&C blue No.1), fast green FCF (FD&C green No.3), lissamine green B, naphthol green or acid green, cochineal, carmoisine azorubin, amaranth, brilliant scarlet 4R, complexes of copper and chrolophyl, brilliant black BN (PN), chocolate brown HT, β-carotin, bixin, lycopene, betanin, Erythrosin B sodium salt and mixtures thereof. The optically transparent oral care composition contains a negligible amount of titanium dioxide and 3% or less of silicone dioxide.
Method of treating destructive forms of chronic periodontitis Method of treating destructive forms of chronic periodontitis / 2510271
Invention relates to medicine, namely therapeutic dentistry and may be used for treating destructive forms of chronic periodontitis. That is ensured by administering a therapeutic preparation into a root canal. A sonic phoresis of the therapeutic preparation Beresh plus drops is preceded by coating the skin surrounding a causative tooth with a therapeutic mixture containing the preparation Beresh plus drops, 10% calcium gluconate and Vaseline oil. Thereafter, an emitter is used to process the area. The sonic phoresis is followed by a root canal obturation with calcium hydroxide. That is combined with administering ascorbic acid in a daily dose of 50-100 mg and the preparation Beresh plus drops 1 drop per 2 kg of body weight a day orally. The therapeutic course is 5-8 procedures.
Oral composition / 2510262
Group of inventions refers to medicine, namely to dentistry, and may be used as an oral composition for controlling an oral sweetener release. The above composition contains a polymer attached to the sweetener by a breakable link comprising a covalent bond, an ester bond or an amide bond. The breakable link is breakable in the oral cavity to release the sweetener. Said polymer is a polymer adhered to the mucosa and specified in methyl vinyl ether/maleic anhydride copolymer with polymer found in the amount of 0.001% to 10%. The sweetener is specified in dextrose, saccharose, maltose, dextrin, dried invert suger, mannose, xylose, ribose, fructose, lexulose, galactose, corn syrup, partially hydrolysed starch, sorbitol, mannitol, isomalt, aspartame, neotame, saccharine and its salts, sucralose, the sweeteners on the basis of dipeptides, cyclamates, dihydrochalcone with the sweetener content making 0.005% to 5%. What is also presented is a portable dispenser, a method for preparing the oral composition, a method for controlling the sweetener in the oral cavity, and using the polymer.
Adhesive ointment for treating oral mucosal involvements in lichen acuminatus / 2508120
Invention refers to pharmaceutical industry, namely to an agent for treating an oral mucosal involvement accompanying lichen acuminatus. An adhesive ointment for treating the oral mucosal involvements accompanying lichen acuminatus containing sea buckthorn oil and 0.5% prednisolone ointment, socoseryl dental adhesive paste and vitamin A in the specific proportions.
Combined soft dosage form for local treatment of periodontics / 2508101
Invention refers to pharmaceutics and represents a combined drug preparation for the local treatment of periodontics, including a complex of metronidazole and chlorhexidine in a combination with sodium fusidine, sweetening agents and a pharmaceutically acceptable gel base in the following proportions, g: sodium fusidine 1.8-2.2; metronidazole 0.9-1.1; chlorhexidine bigluconate (in the form of 20% chlorhexidine bigluconate) 0.42-0.58 in the amount equivalent to chlorhexidine 0.08-0.12; sodium saccharinate 0.1-0.3; monoammonium glycerrhizinate (MM100) 0.006-0.008; aerosil 200 (colloidal silicon dioxide) 5.5-6.0; paraffin oil (Vaselin oil) - the rest up to 100 g.
Method for treatment and prevention of oral complications caused by hormonal preparation inhalations in patients suffering bronchial asthma / 2506080
Invention refers to medicine, namely to dentistry, and may be used for treating oral candidiasis caused by hormonal preparation inhalations in the patients suffering bronchial asthma. For this purpose, the dental clinical-laboratory analysis and diagnosing of candidiasis is followed by prescribing 1% antimycotic agent of imidazole derivatives for oral preparation 2-3 times a day, a preparation with the active substance GMDP (glucosaminyl-muramyl dipeptide) 10 mg once a day 30 minutes before meals for 10 days, and using a toothpaste and Elmex mouthwash.
Method for dental restoration and method for making restoration material / 2521195
Group of inventions refers to medicine, namely to dentistry, and may be used for making a restoration material used for partial dental restoration in the oral cavity. That is ensured by placing the first cell mass formed by mesenchymal or epithelial cells/cell and a second cell mass formed by other mesenchymal or epithelial cells/cell on a carrier. One of the mesenchymal or epithelial cells is made from a dental germ, and the above cell masses are placed in tight contact to each other, but not mixed. The above cell masses are grown to form the whole restored tooth or its germ. That is followed by localising the whole restored tooth or its germ grown that enables implanting the whole restored tooth or is germ within the lost tooth so that a dental crown is directed inside the oral cavity with the dental germ or the tooth being used as the restoration material for preparing an equivalent of the lost tooth within the lost tooth area.
Matrix for cell transplantology / 2521194
Invention refers to cell transplantology and tissue engineering, and describes a matrix, a basic element of which is a flat plate made from a spatially cross-linked hydrophobic polymer containing hydrophilic groups and forming on the plate surface a layer of saturated hydrocarbons having a chain length of 8 to 16 carbon atoms and directed preferentially along the normal line to the plate surface. The spatially cross-linked polymer is formed on substrates by exposing a photopolimerisable composition containing oligourethane methacrylate, a methacrylate monomer having a chain length of 8 to 18 carbon atoms, 2,2-dimethoxy-2-phenylacetophenone and 2,4-ditertbutylorthquinone, to light at a wave length of 320-380 nm.
Tubule-closing materials from silicon dioxide for tooth care preparations / 2520747
Group of inventions relates to precipitated materials from silicon dioxide for application as abrasive substances or thickening agents in preparations for tooth care, which are simultaneously efficient for closing dentinal tubules in order to reduce dentin sensitivity. The claimed precipitated material from silicon dioxide has an average size of particles from 1 to 5 microns and contains a metal adduct, present on at least a part of its surface for formation of a metal adduct-processed precipitated material from silicon dioxide, which demonstrates more than 10% reduction of zeta-potential in comparison with precipitated material from silicon dioxide of the same structure but without the metal adduct. Also claimed are: versions of tooth care preparation, containing the said precipitated material from silicon dioxide and a method of processing teeth of a mammal with application of such preparations.
Therapeutic composition for treating bronchitis and method for preparing it / 2520745
Invention refers to the pharmaceutical industry, particularly to a pharmaceutical composition for treating bronchitis. The pharmaceutical composition for treating bronchitis contains a SCUTELLARIAE RADIX powder; an essence of mixed CITRI RETICULATAE PERICARPIUM and CINNAMOMI RAMULUS; a concentrated aqueous extract of herbal residue of the essence process, and mixed ATRACTYLODIS MACROCEPHALAE RHIZOMA, PORIA, GLYCYRRHIZAE RADIX ET RHIZOMA, FARFARAE FLOS, FORSYTHIAE FRUCTUS; a concentrated ethanol extract of PINELLIAE RHIZOMA, PERILLAE FRUCTUS, SINAPIS SEMEN, RAPHANI SEMEN, ASTERIS RADIX ET RHIZOMA, HOUTTUYNIAE HERBA, ARMENIACAE SEMEN AMARUM.
Wetting agent for skin and using it / 2520743
Invention refers to the cosmetic industry, namely a wetting agent for the skin. A wetting composition for the skin containing water, glycerol, butyrospermum parki, cyclopentasiloxane, a sodium pyrrolidone carboxylic acid, panthenol, demethiconol, optionally sodium polyacrylate taken in certain proportions, as well as fatty ingredients, an emulsion stabiliser, a preserving agent and/or a pH adjuster. Using the composition for hydration or moistening of the skin in need thereof. Using the composition for the skin hydration for the first two hours after application. A method for the skin hydration.
Method of treating spinal malignant tumours and spinal metastases of tumours / 2520682
Invention refers to medicine, namely to oncology and radiotherapy, and may be used for treating patients with spinal malignant tumours and spinal metastases of tumours accompanied by anticipated or complicated spinal disorders. That is ensured by introducing bone cement into the tumour growth centres. The bone cement formulation is specified so that its polymerisation is accompanied by generating heat sufficient to provide thermal sensibilisation of the tumour cells, and β- and γ-radionuclides are added to the cement.
Composition for preventing or treating malignant new growth containing active ingredient presented by herbal stem cell line recovered from cambium of panax ginseng, including wild ginseng or ginseng / 2520625
Invention refers to a composition for treating a malignant new growth, as well as for improving health condition in the malignant new growth. The pharmaceutical composition for treating the malignant new growth which contains one or more substances specified in a group consisting of a cell line, its extract and its culture medium, wherein the cell line is recovered from cambium of Panax ginseng. A functional foodstuff for improving health condition in the malignant new growth.
Cosmetic composition containing culture cells of yew (taxus) stem cambium or procambium / 2520606
Invention refers to using one or more cell lines originated from yew (Taxus) stem cambium or procambium, an extract thereof, and a medium wherein cultured for preparing an antioxidant, anti-inflammatory or anti-aging composition, wherein (a) the cells are undifferentiated at first, and (b) the cell culture is stable with a rate of growth higher than in the cell line originated from different tissues, other than Taxus cambium or procambium. The compositions according to the invention as compared to the existing antioxidant and anti-inflammatory agents minimise side effects; they are involved into intracellular metabolic processes reducing a quantity of intracellular active oxygen forms, and relieve age signs. The prepared compositions according to the invention are effective to prevent and delay ageing.
Spin-labelled kynurenine derivative and method for production thereof Spin-labelled kynurenine derivative and method for production thereof / 2519951
Invention relates to a novel spin-labelled kynurenine derivative having the structural formula: A method of producing said compound is also described.
Agent possessing antineoplastic and immunomodulatory action Agent possessing antineoplastic and immunomodulatory action / 2519769
Agent possessing antineoplastic and immunomodulatory action, representing a dry extract of drug hedge hyssop leaves and blossom, prepared by their milling, extracting in alcohol on a water bath until boils, and boiling, distillation, dilution of the distilled residue with distilled water first, adding chloroform, cooling to room temperature and centrifuging with separating a water fraction and drying under certain conditions.
Method of treating urethral syndrome in females Method of treating urethral syndrome in females / 2509556
Invention refers to medicine, namely medicine, and may be used for treating urethral syndrome in females with using the antibacterial preparation gentamycin. Gentamycin is introduced into a urethral wall in the amount of 80 mg dissolved in anaesthetic solution 2 ml. The above preparation is introduced in parallel with the urethral wall. The anaesthetic is presented by 0.25% Novocaine. That is followed by a vulvar exposure to an infrared laser light at wave length 0.82 mcm, frequency 3000 Hz, and power 10 mWt. A procedure length makes 5-6 minutes; the therapeutic course is 8-10 procedures.

FIELD: medicine.

SUBSTANCE: method of treating apical periodontitis involves necrectomy from root canals, mechanical treatment thereof, root canal widening with multiple administration of a solution therein, insertion of a drain sponge wetted with the solution into the root canals left until the next doctor's appointment, root canal orifice closure with a dressing, root canal opening 48 hours later, dressing removal from the root canals, processing with 2% aqueous sodium hypochlorite, and gutta-percha filling. Mechanical treatment involves multiple introduction of a butol solution; mechanical treatment is followed by inserting drain sponges wetted in the butol solution into the root canals, or by introducing mixed zinc sulphate cement with butol with using a root canal filling instrument.

EFFECT: provided haemostatic effect in the root canal, optimal drug diffusion into the root canal tissues, and an anti-inflammatory action.

2 ex

 

The invention relates to medicine, namely to dentistry, and can be used for the treatment of apical periodontitis.

There is a method of treatment of apical periodontitis, which consists in the medical treatment of cavities and root canals of the tooth before filling ozonated isotonic sodium chloride with a concentration of ozone 4500-6000 ág/l, giving each root canal 10-15 ml for 5-10 minutes [1].

The disadvantage of this method is that it does not provide a hemostatic effect in the root canal may not have sufficient anti-inflammatory effect through the use of a drug with a narrow spectrum of antimicrobial action, does not provide optimal diffusion of the drug into the tissue of the root canal.

There is a method of treatment of apical periodontitis, which consists in the carious cavity preparation, mechanical and medical treatment of the root canal, the introduction into the root canal on the day of the sorbent SUMS-1, chopped to the size of the granules of 0.02-0.1 mm, after removal of the sorbent in the periapical tissues through the channel introduce a 1% solution of vilone for 3-5 minutes, the root canal is sealed toothpaste, calcium hydroxide, zinc oxide and 1% solution of vilone in a volume ratio 1:1:0,5 [2].

Defects in the current of this method is what it does not provide a hemostatic effect in the root canal may not have sufficient anti-inflammatory effect through the use of a drug with a narrow spectrum of antimicrobial action, does not provide optimal diffusion of the drug into the tissue of the root canal, facilitates the connection of the drug with proteins and education autoantigenic sensitizing complexes.

There is a method of treatment of apical periodontitis, which consists in mechanical and medical treatment of the root canal, filling, root canal "Leptomycin Forte" with the help of Canaanites, the closing of the tooth airtight bandage. When you visit Leptomycin Forte" is removed from the root canal, the canal is cleaned and sealed by hardening material [3].

The disadvantage of this method is that it does not provide a hemostatic effect in the root canal may not have sufficient anti-inflammatory effect through the use of a drug with a narrow spectrum of antimicrobial action, does not provide optimal diffusion of the drug into the tissue of the root canal, facilitates the connection of the drug with proteins and education autoantigenic sensitizing complexes.

There is a method of treatment of apical periodontitis, including the store mechanical necrosectomy of the root canal, their machining and expansion. Upon expansion of the canal of the tooth repeatedly impose 5% solution of metronidazole, and then in the channel insert turundas moistened with a solution of Polyoxidonium, which leave until the next doctor's visit. The mouth of the channel is closed by the drug "Sandarac Plus. After 48 hours, the tooth canal is opened, treated with 2% aqueous solution of sodium hypochlorite, 5% solution of metronidazole and sealed with gutta percha [4].

The disadvantage of this method is that it does not provide a hemostatic effect in the root canal may not have sufficient anti-inflammatory effect through the use of a drug with a narrow spectrum of antimicrobial action, does not provide optimal diffusion of the drug into the tissue of the root canal, facilitates the connection of the drug with proteins and education autoantigenic sensitizing complexes. This method is used for the prototype.

The aim of the invention are to provide a hemostatic effect in the root canal, sufficient anti-inflammatory action, optimal diffusion of the drug into the tissue of the root canal. This goal is achieved by the fact that in the root canal of a tooth during mechanical processing is repeatedly injected solution butola, after machining the root to the Nala tooth impose pads moistened with a solution of butola, or after the machining of the root canals of the tooth, with the help of Canaanites, introducing a mixture of zinc-sulphate cement butola.

The method of treatment apical periodontitis is used as follows. Under adequate anesthesia produce carious cavity preparation, the opening of the cavity, necrosectomy, expansion and formation of the cavity, drug treatment, the opening of cavity of tooth, amputation of the crown and the mouth of the pulp with opening mouths of the root canals of the tooth. Make necrosectomy of the root canal of the tooth, machining and expansion. In the root canal of a tooth during mechanical processing is repeatedly injected solution butola, after mechanical treatment of the root canals of the tooth impose pads soaked in the solution butola, or after the machining of the root canals of the tooth, with the help of Canaanites, introducing a mixture of zinc-sulphate cement butola. Leave turundas or filling material to your next visit in the root canals of the tooth as a bandage, cover the mouth of the root canals of the tooth band. After 48 hours, in the absence of complaints and objective signs of inflammation, open the root canals of the tooth, remove the bandage from the root canal of a tooth treated with a root Cana the crystals of the tooth 2% aqueous solution of sodium hypochlorite, sealed root canals, produce tooth restoration.

Using the new method and the results of its application are confirmed by examples. The method presents the following examples.

Clinical example 1. Patient M., 24 years. The diagnosis of Chronic periodontitis of the tooth 1.6. Under local anesthesia Sol.Ultracaini - 1,7 ml produced carious cavity preparation, the opening of the cavity, necrosectomy, expansion and formation of the cavity, drug treatment, the opening of cavity of tooth, amputation of the crown and the mouth of the pulp with opening mouths of the root canals of the tooth. Made necrosectomy of the root canal of the tooth, machining and expansion. In the root canal of a tooth during mechanical processing is repeatedly entered the solution butola, after mechanical treatment of the root canals of the tooth entered pads soaked in the solution butola. The pads moistened with butola left until the next doctor's visit in the root canals of the tooth as bandages, mouth of the root canals of the tooth are closed bandage. After 48 hours, in the absence of complaints and objective signs of inflammation, the root canals of the tooth is opened, the dressing of the root canal of the tooth is removed, the root canals of a tooth treated with 2% aqueous sodium hypochlorite solution, root canals filled with gutta-percha with syler H+produced guests the tooth Filtec Supreme XT. Recommendations are given. After 7 days there are no complaints, percussion painless. After 2 months - depression in the periapical tissues is missing.

Clinical example 2. Patient J., 18 years. The diagnosis of Chronic periodontitis of the tooth 3.7. Under local anesthesia Sol.Ultracaini - 1,7 ml produced carious cavity preparation, the opening of the cavity, necrosectomy, expansion and formation of the cavity, drug treatment, the opening of cavity of tooth, amputation of the crown and the mouth of the pulp with opening mouths of the root canals of the tooth. Made necrosectomy of the root canal of the tooth, machining and expansion. In the root canal of a tooth during mechanical processing is repeatedly entered the solution butola, after mechanical treatment of the root canals of the tooth, with the help of Canaanites entered a mixture of zinc-sulphate cement butola. A mixture of zinc-sulphate cement butola left until the next doctor's visit in the root canals of the tooth as bandages, mouth of the root canals of the tooth are closed bandage. After 48 hours, in the absence of complaints and objective signs of inflammation, the root canals of the tooth is opened, the dressing of the root canal of the tooth is removed, the root canals of a tooth treated with 2% aqueous sodium hypochlorite solution, root canals filled with gutta-percha with syler N+, manufactured restaura the Oia tooth Filtec Supreme XT. Recommendations are given. After 7 days there are no complaints, percussion painless. After 2 months - depression in the periapical tissues is missing.

The positive effect from the use of the proposed method is that in the treatment of chronic apical periodontitis method provides a hemostatic effect in the root canal, anti-inflammatory, optimal diffusion of the drug into the tissue of the root canal.

The proposed model can be used in dental offices dentistry and outpatient dental settings.

SOURCES of INFORMATION

1. Patent No. 2279279, application No. 2005103981/14 from 16.02.2005.

2. Patent No. 2472465, application No. 2011125738/14 22.06.2011.

3. Practical therapeutic dentistry: Educational. Manual/ Ahinigopiv, Limcaoco.- 8th ed., supplementary And processed): Medpress-inform, 2008.-s-711.

4. Patent No. 2370238, application No. 2008103714/14, 06.02.2008.

A method for the treatment of apical periodontitis, including necrosectomy of the root canal of the tooth, mechanical processing, the expansion of the root canal of a tooth with multiple introducing solution, introduction into the root canal of the tooth pads soaked in the solution, and leaving it until the next visit to the doctor, closing the mouths of the root canals of the tooth band, the opening of the root canal of the tooth 48 is aces, remove the dressing from the root canals of the tooth, the treatment of 2% aqueous sodium hypochlorite solution, sealing the gutta percha, characterized in that the root canal of a tooth during mechanical processing is repeatedly injected solution butola, after mechanical treatment of the root canals of the tooth impose pads soaked in the solution butola, or after the machining of the root canals of the tooth, with the help of Canaanites, introducing a mixture of zinc-sulphate cement butola.

 

© 2013-2014 Russian business network RussianPatents.com - Special Russian commercial information project for world wide. Foreign filing in English.